Shareholder in CLOV (CLOV) registers 474,801 shares for potential sale

Rhea-AI Filing Summary

A shareholder has filed to sell common stock. A holder working through Morgan Stanley Smith Barney LLC Executive Financial Services registered up to 474,801 common shares, with an aggregate market value of $2,171,597.33, for potential sale on or after 08/14/2026 on NASDAQ. The filing also lists multiple restricted stock and performance share awards from the issuer and discloses prior sales within the last three months.

Key Figures

Shares registered for potential sale: 474,801 shares Aggregate market value of registered shares: $2,171,597.33 Recent shares sold: 441,601 shares +3 more

6 metrics

Shares registered for potential sale 474,801 shares Common stock covered by resale notice through Morgan Stanley Smith Barney LLC

Aggregate market value of registered shares $2,171,597.33 Total market value associated with 474,801 common shares

Recent shares sold 441,601 shares Common shares sold on 08/07/2026 by Brady Priest

Proceeds from recent sale $2,141,988.87 Total consideration for 441,601 common shares sold on 08/07/2026

Performance shares line item 107,010 shares Performance Shares from issuer dated 09/13/2024

Restricted stock line item 67,373 shares Restricted Stock from issuer dated 01/18/2025

Key Terms

Restricted Stock, Performance Shares, Securities To Be Sold, Securities Sold During The Past 3 Months

4 terms

Restricted Stock financial

"Common | 07/18/2025 | Restricted Stock | Issuer |"

Shares granted to an individual that carry limits on transfer or sale until certain conditions are met, such as staying with the company for a set time or hitting performance targets. Think of them as a locked gift that gradually opens; for investors they matter because they affect how many shares may enter the market later, signal management incentives and potential dilution, and reveal confidence in future company performance.

Performance Shares financial

"Common | 09/13/2024 | Performance Shares | Issuer |"

Performance shares are a type of company stock given to executives or employees that only become theirs if the company meets specific goals, like hitting certain profits or growth targets. They motivate leaders to work toward the company’s success, because their additional shares depend on achieving these results.

Securities To Be Sold financial

"144: Securities To Be Sold"

Securities Sold During The Past 3 Months financial

"144: Securities Sold During The Past 3 Months"

FAQ

What does the Form 144 filing mean for CLOV shareholders?

The filing indicates a shareholder registered up to 474,801 common shares with an aggregate value of $2,171,597.33 for potential sale via a broker. It is a notice of possible resales, not a confirmation that all shares will be sold.

How many CLOV shares are proposed to be sold in this notice?

The notice covers up to 474,801 common shares. This amount is tied to an aggregate market value of $2,171,597.33 and reflects the maximum number of shares registered in this resale notice.

Which broker is handling the potential CLOV share sales?

The shares are to be sold through Morgan Stanley Smith Barney LLC Executive Financial Services, based at 1 New York Plaza, 8th Floor, New York, NY 10004. This broker is listed as handling the common stock transactions on NASDAQ.

What prior CLOV share sales are disclosed in the last 3 months?

The filing reports that 441,601 common shares were sold on 08/07/2026 for total proceeds of $2,141,988.87 by Brady Priest. This section summarizes recent sales relevant to the current resale notice.

What types of CLOV equity awards are listed in the Form 144?

The document lists several Restricted Stock and Performance Shares grants from the issuer with grant dates such as 09/13/2024 and 07/18/2025. Each line shows the number of shares and an associated date for potential sale.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Available on EDGAR 08/14/2026 - 07:17 PM Accepted by SEC EDGAR 08/14/2026 - 07:17 PM Learn about SEC filing dates

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK
Filer CCC
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer

SEC File Number

Address of Issuer

Phone

Name of Person for Whose Account the Securities are To Be Sold

See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.

Relationship to Issuer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common	Morgan Stanley Smith Barney LLC Executive Financial Services 1 New York Plaza 8th Floor New York NY 10004	474801	2171597.33	435441337	08/14/2026	NASDAQ

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common	07/18/2025	Restricted Stock	Issuer			57627	07/18/2025	Not Applicable
Common	10/18/2024	Restricted Stock	Issuer			57627	10/18/2024	Not Applicable
Common	01/18/2025	Restricted Stock	Issuer			67373	01/18/2025	Not Applicable
Common	04/18/2025	Restricted Stock	Issuer			67671	04/18/2025	Not Applicable
Common	04/30/2025	Restricted Stock	Issuer			29920	04/30/2025	Not Applicable
Common	10/31/2024	Restricted Stock	Issuer			57654	10/31/2024	Not Applicable
Common	07/31/2025	Restricted Stock	Issuer			29919	07/31/2025	Not Applicable
Common	09/13/2024	Performance Shares	Issuer			107010	09/13/2024	Not Applicable

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Name and Address of Seller	Title of Securities Sold	Date of Sale	Amount of Securities Sold	Gross Proceeds
BRADY PRIEST 1209 Orange Street Wilmington DE 19801	Common	08/07/2026	441601	2141988.87

144: Remarks and Signature

Remarks

Date of Notice

ATTENTION:

The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.

Signature

ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)